**Question:** Inotropic drugs acts on which receptors: March 2013

**Core Concept:** Inotropic drugs are medications that increase contractility of cardiomyocytes, primarily targeting the myocardium. They are divided into two main categories: positive inotropes and negative inotropes, based on their effect on cardiac contractility.

**Why the Correct Answer is Right:**
D-Dopamine is a positive inotropic drug that acts on beta-1 adrenergic receptors (β1ARs) and dopamine receptors (DA receptors), primarily D1 and D3. These receptors are part of the cAMP-PKA pathway, which promotes cardiac contractility. Inotropic drugs like dobutamine, dopexamine, and epinephrine also target β1ARs.

**Why Each Wrong Option is Incorrect:**

A. Negative inotropic drugs like β-blockers like propranolol and atenolol are not related to the question, as they act on β-adrenergic receptors (β-ARs) to decrease cardiac contractility.

B. Calcium channel blockers like nifedipine and verapamil are also unrelated to the question, as they act on voltage-gated calcium channels, affecting myocardial contractility indirectly.

C. Antagonists like naloxone, which blocks opioid receptors, are not in the context of inotropic drugs and their receptors.

**Clinical Pearl / High-Yield Fact:**
The understanding of inotropic drug receptors and their mechanism of action is crucial for managing critically ill patients with cardiac dysfunction, such as cardiomyopathy, sepsis-induced myocardial depression, and post-cardiac surgery patients. Choosing the appropriate inotropic drug based on the receptor stimulation can lead to better cardiac output and organ perfusion, ultimately improving overall patient outcomes.